We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Decide Who Gets Marketing Exclusivity for Generic Norvasc
FDA to Decide Who Gets Marketing Exclusivity for Generic Norvasc
April 17, 2007
The FDA is set to make a decision soon that could determine who gets to market generic Norvasc with six months exclusivity.